Nephros Inc NEPH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $3.64
- Day Range
- $3.54–3.80
- 52-Week Range
- $2.66–6.42
- Bid/Ask
- $3.65 / $3.89
- Shares Outstanding
- 10.86M
- Market Cap
- $40.82M
- Volume/Avg
- 12,562 / 21,220
Key Statistics
- Price/Earnings (Normalized)
- 53.71
- Price/Sales
- 2.17
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 36
- Website
- https://www.nephros.com
Valuation
|
Metric
|
NEPH
|
|---|---|
Price/Earnings (Normalized) | 52.00 |
Price/Book Value | 3.69 |
Price/Sales | 2.11 |
Price/Cash Flow | 25.23 |
Price/Earnings
NEPH
Financial Strength
|
Metric
|
NEPH
|
|---|---|
Quick Ratio | 2.98 |
Current Ratio | 4.55 |
Interest Coverage | — |
Quick Ratio
NEPH
Profitability
|
Metric
|
NEPH
|
|---|---|
Return on Assets (Normalized) | 8.02% |
Return on Equity (Normalized) | 10.42% |
Return on Invested Capital (Normalized) | 8.23% |
Return on Assets
NEPH
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|m<HcfDQ | LOCK|#M# | $138B | |||
| Becton Dickinson & Co
BDX
| LOCK|P%Z | LOCK|fhygN | $43B | |||
| Alcon Inc
ALC
| LOCK|cD&sl! | LOCK|FD%VV | $33B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|gb<&s! | LOCK|g&F$$ | $33B | |||
| ResMed Inc
RMD
| LOCK|>&@$dmTd | LOCK|CB?&q | $29B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|YfgL^LS | LOCK|sR | $25B | |||
| The Cooper Companies Inc
COO
| LOCK|@!<%!YY | LOCK|PpFwz | $14B | |||
| Solventum Corp
SOLV
| LOCK|%j#@!?q | LOCK|Q?Y | $14B | |||
| Align Technology Inc
ALGN
| LOCK|s&nbr> | LOCK|!K@v& | $13B | |||
| Baxter International Inc
BAX
| LOCK|PC | LOCK|!XBy@ | $11B |
United States